Annovis Bio, Inc. (ANVS)
2.38
-0.03
(-1.24%)
USD |
NYSE |
Feb 20, 12:36
Annovis Bio EPS Diluted (Quarterly) : -0.3689 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avanos Medical, Inc. | -0.0302 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.263M |
| Total Expenses (Quarterly) | 7.263M |
| Enterprise Value | 48.59M |
| Earnings Yield | -62.33% |
| Normalized Earnings Yield | -64.65 |